Keywords: India, Biosimilars, Market, Datamonitor

Can India become a biosimilar powerhouse?

Article | 08 February 2011

Indian manufacturers are ideally placed to capitalize on the growing biosimilars market, according to independent market analyst Datamonitor. Although the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in